Decreased Mortality of COVID-19 With Renin-Angiotensin-Aldosterone System Inhibitors Therapy in Patients With Hypertension: A Meta-Analysis

Hypertension. 2020 Aug;76(2):e13-e14. doi: 10.1161/HYPERTENSIONAHA.120.15572. Epub 2020 May 27.

Authors

Xiaoming Guo^#¹, Yueli Zhu^#², Yuan Hong¹

Affiliations

¹ From the Departments of Neurosurgery (X.G., Y.H.), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.
² Neurology (Y.Z.), The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, China.

^# Contributed equally.

PMID: 32458694
DOI: 10.1161/HYPERTENSIONAHA.120.15572

No abstract available

Keywords: global health; humans; hypertension; pandemics; renin-angiotensin system.

Publication types

Letter
Meta-Analysis

MeSH terms

Angiotensin Receptor Antagonists / therapeutic use*
Angiotensin-Converting Enzyme Inhibitors / therapeutic use*
Betacoronavirus*
COVID-19
Coronavirus Infections / complications
Coronavirus Infections / drug therapy*
Coronavirus Infections / mortality
Global Health
Humans
Hypertension / complications
Hypertension / drug therapy*
Hypertension / mortality
Pandemics
Pneumonia, Viral / complications
Pneumonia, Viral / drug therapy*
Pneumonia, Viral / mortality
Renin-Angiotensin System / drug effects*
SARS-CoV-2
Survival Rate / trends

Substances

Angiotensin Receptor Antagonists
Angiotensin-Converting Enzyme Inhibitors